Skip to main content

Table 3 Interactive analysis of MetS and HDL

From: Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients

MetS

HDL

Model I (OR, 95%CI) P

Model II (OR, 95%CI) P

No

Low

Ref

Ref

Yes

Low

0.2 (-4.7, 5.1) 0.9299

0.5 (-4.7, 5.8) 0.8464

No

Middle

12.6 (-2.7, 27.9) 0.1141

24.3 (0.9, 47.7) 0.0483

Yes

Middle

18.9 (2.1, 35.7) 0.0327

31.3 (6.2, 56.3) 0.0191

No

High

-0.6 (-20.9, 19.7) 0.9547

0.3 (-21.4, 22.0) 0.9781

Yes

High

-0.4 (-21.9, 21.0) 0.9688

1.1 (-21.8, 24.1) 0.9224

P for interaction

 

0.0261

0.0152

  1. MetS Metabolic syndrome, HDL High-density lipoprotein, Model I Adjusted for Age, BMI, Gestation, Parity, model II Adjusted for Age, BMI, Gestation, Parity, FBG, PCOS